FLNC and dilated cardiomyopathy: By administering tamoxifen treatment at 2 months of age, authors ablated FLNC in icKO hearts, thus leading to the development of dilated cardiomyopathy within 2 weeks and the death of 73% of Flnc-icKO mice by 25 weeks [25].